Floxuridine
Back to searchMolecule Structure
Scientific Name
Floxuridine
Description of the Drug
Floxuridine is an antimetabolite used as palliative management for liver metastases of gastrointestinal malignancy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00322
http://www.drugbank.ca/drugs/DB00322
Brand Name(s)
Floxuridine, Fudr, F.u.d.r.
Company Owner(s)
Hospira Inc, Fresenius Kabi Usa Llc, Hikma Pharmaceuticals Usa Inc, American Regent Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thymidylate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1952 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4424 | ||||||
| Human Metabolome Database | HMDB0014467 | ||||||
| DrugBank | DB00322 | ||||||
| PubChem: Thomson Pharma | 14749705 | 14749704 | |||||
| PubChem | 5790 | ||||||
| Mcule | MCULE-4890053166 | ||||||
| LINCS | LSM-5588 | ||||||
| Nikkaji | J4.488A | ||||||
| BindingDB | 50340678 | ||||||
| EPA CompTox Dashboard | DTXSID3023057 | ||||||
| DrugCentral | 1184 | ||||||
| Brenda | 77908 | 43538 | 113382 | 24238 | 24240 | 3318 | 3977 |
| ChemicalBook | CB3210097 | ||||||
| Guide to Pharmacology | 4801 | ||||||
| rxnorm | FLOXURIDINE | ||||||
| KEGG Ligand | C11736 | ||||||
| ChEBI | 60761 | ||||||
| ZINC | ZINC000003813010 |
